YORK PHARMA
YORK PHARMA is a speciality pharmaceutical company. There stated objective is the acquisition, development and commercialisation of prescription dermatological products. They are committed to bringing to both patients and healthcare professionals, safe and effective medicines of the highest quality for the treatment of diseases of the skin. Successful treatments for use in the surgery, clinic and hospitals also drive a successful and growing public company. This benefits there shareholders and employees and allows them to continue to develop products which offer benefits to patients over and above those provided by existing treatments.
YORK PHARMA
Social Links:
Industry:
Biotechnology Health Care Robotics
Founded:
2002-06-20
Address:
Milton Keynes, Milton Keynes, United Kingdom
Country:
United Kingdom
Website Url:
http://www.yorkpharma.com
Total Employee:
11+
Status:
Closed
Contact:
+44 (0)1908 764020
Email Addresses:
[email protected]
Technology used in webpage:
SPF Amazon Amazon Virginia Region NameBright
Similar Organizations
PregLem
PregLem is a Swiss based specialty biopharmaceutical company dedicated to the development and commercialisation of innovative drugs for
Leadiant Biosciences
Leadiant Biosciences is a pharmaceutical company dedicated to the development, registration and commercialization of effective therapies.
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2008-10-28 | CellTran | CellTran acquired by York Pharma | N/A |
| 2005-02-02 | Molecular Skincare | Molecular Skincare acquired by York Pharma | N/A |
Official Site Inspections
http://www.yorkpharma.com
- Host name: ec2-13-223-25-84.compute-1.amazonaws.com
- IP address: 13.223.25.84
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "York Pharma"
About Us - York Pharma
Sep 12, 2024 At York Pharma, we understand that true health is about more than just treating symptoms; it’s about preventing disease, promoting wellness, and offering holistic solutions …See details»
York Pharma - Crunchbase Company Profile & Funding
YORK PHARMA is a speciality pharmaceutical company. There stated objective is the acquisition, development and commercialisation of prescription dermatological products. They are …See details»
York Pharma Gmbh - Drug pipelines, Patents, Clinical trials - Synapse
Jan 23, 2025 Explore York Pharma Gmbh with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, Disease Domain:Infectious Diseases, Technology Platform:Small …See details»
York Pharma - 2025 Company Profile - Tracxn
Mar 21, 2025 York Pharma was a speciality pharmaceutical company focussed on the acquisition, development, and commercialisation of prescription dermatological products. Its …See details»
York Pharma - Funding, Financials, Valuation & Investors
YORK PHARMA is a speciality pharmaceutical company. There stated objective is the acquisition, development and commercialisation of. New. Resources. ... Log In. Experience the new …See details»
York Pharma plc - VentureRadar
Acquisition, development and commercialisation of prescription dermatological products ... Find out more about York Pharma plc, Life sciences and Healthtech and Life Sciences.See details»
York Pharma (Group) - life-sciences-europe.com
Aug 1, 2003 Berenberg European Conference USA 2025 New York; RBC Capital Markets Global Healthcare Conference 2025 New York; SLAS Europe 2025 Hamburg » More Events! …See details»
York Pharma (R&D) Ltd. - Drug pipelines, Patents, Clinical trials
Explore York Pharma (R&D) Ltd. with its drug pipeline, therapeutic area, technology platform, . Explore York Pharma (R&D) Ltd. with its drug pipeline, therapeutic area, technology platform, . …See details»
York Pharma - Products, Competitors, Financials, Employees ...
Dec 9, 2013 About York Pharma. YORK PHARMA is a speciality pharmaceutical company. The company's stated objective is the acquisition, development and commercialisation of …See details»
York Pharma Company Profile 2024: Valuation, Funding
York Pharma General Information Description. Provider of prescription products. The company company is engaged in developing, marketing and supplying prescription products to …See details»
York Pharma Plc - Drug pipelines, Patents, Clinical trials - Synapse
Explore York Pharma Plc with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, and 2 literature, Drug:YP-001, Carbenoxolone Sodium, RPL-208, S1P (York Pharma), …See details»
York Pharma - Founders and Board of Directors - Tracxn
Mar 21, 2025 York Pharma's founder is Terry Sadler. Corporates and Startups. Corp Dev and M&A Teams Corporate Innovation Startup Founders Sales TeamSee details»
What is York Pharma? Company Culture, Mission, Values
See what employees say it's like to work at York Pharma. Salaries, reviews, and more - all posted by employees working at York Pharma.See details»
York Pharma - Crunchbase
YORK PHARMA is a speciality pharmaceutical company. There stated objective is the acquisition, development and commercialisation ofSee details»
Simplification for success: Rewiring the biopharma operating model
Mar 21, 2025 Pharma companies should identify the capabilities that are essential for their future portfolios and differentiate between areas where they must excel and those where industry …See details»
York Pharma buys brands from Solvay - The Pharma Letter
Oct 12, 2008 UK-based York Pharma has purchased the worldwide commercial rights to two leading skin care and wound healing products. At the same time, the firm has raised $51.2 …See details»
Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune …
This was a phase I, first-in-human, dose escalation/expansion study in patients with progressive mCRPC after treatment with ≥one androgen signaling inhibitors (ClinicalTrials.gov identifier: …See details»
York Pharma - Tech Stack, Apps, Patents & Trademarks - Crunchbase
YORK PHARMA is a speciality pharmaceutical company. There stated objective is the acquisition, development and commercialisation ofSee details»
How Big Pharma helped build the factory farm meat industry - Vox
Mar 1, 2025 Jeff Simmons, president and CEO of Elanco Animal Health Inc., center, applauds while ringing the opening bell on the floor of the New York Stock Exchange in 2018. Michael …See details»
YP-001 - Drug Targets, Indications, Patents - Synapse - Patsnap
YP-001: a Peptide hydrolase inhibitors Drug, Initially developed by York Pharma Gmbh, Now, its global highest R&D status is Discontinued, Mechanism: Peptide hydrolase inhibitors, …See details»